PDCD4: A Double-Edged Sword in Neurological Diseases.

Area of Science:

• Neuroscience
• Molecular Biology
• Oncology

Background:

• Programmed Cell Death 4 (PDCD4) exhibits context-dependent functions, acting as a tumor suppressor in gliomas and a detrimental factor in neuroinflammatory and degenerative diseases.
• PDCD4 dysregulation is clinically significant, contributing to disease progression in both cancer and neurological conditions.
• Its dual role is influenced by molecular environments, mRNA targets, and regulatory networks.

Purpose of the Study:

• To elucidate the dualistic functions of Programmed Cell Death 4 (PDCD4) in neuro-oncology versus neuroinflammation and neurodegeneration.
• To understand the molecular mechanisms governing PDCD4's context-specific roles and dysregulation.
• To identify therapeutic strategies targeting PDCD4 for brain disorders.

Main Methods:

• Analysis of PDCD4 regulation in glioma (e.g., promoter methylation, miR-21 inhibition, FAT1-STAT1 axis).
• Investigation of PDCD4's role in neural injury and neurodegeneration (e.g., MAPK/NF-κB, NLRP3 inflammasome, apoptosis, ferroptosis, BDNF suppression).
• Examination of regulatory networks including miRNA, epigenetics, and ceRNA mechanisms.

Main Results:

• In gliomas, PDCD4 downregulation impairs anti-tumor functions, including cell cycle arrest and apoptosis.
• In neurodegenerative conditions, PDCD4 upregulation promotes inflammation, neuronal death, and hinders repair by suppressing neurotrophic factors.
• A complex regulatory network, particularly involving miR-21, controls PDCD4's expression and activity.

Conclusions:

• PDCD4's opposing roles in brain diseases necessitate context-specific therapeutic approaches.
• Further research is required to fully understand PDCD4 regulatory synergies, cell-type-specific functions, and interactions.
• Multi-omics and cell-specific tools are crucial for deciphering PDCD4 mechanisms and developing targeted treatments.